Indeed, compared with the GSCs derived from clinically obtained GBM samples that potentially harbour multiple genetic mutations52, PTEN-deficient human NSCs show milder phenotypes in intracranial implantation assay, and do not show aggressive growth in non-neural microenvironment. The gene discussed is PTEN; the disease is glioblastoma.